Provided by Tiger Trade Technology Pte. Ltd.

Azitra Inc

0.1263
-0.0007-0.55%
Post-market: 0.12870.0024+1.90%19:49 EDT
Volume:357.58K
Turnover:45.96K
Market Cap:2.05M
PE:-0.05
High:0.1300
Open:0.1300
Low:0.1260
Close:0.1270
52wk High:1.51
52wk Low:0.1000
Shares:16.19M
Float Shares:12.13M
Volume Ratio:0.35
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3107
EPS(LYR):-2.2479
ROE:-158.71%
ROA:-81.79%
PB:0.20
PE(LYR):-0.06

Loading ...

Azitra - Single Dose Ex Vivo Study Shows Improved Elasticity and Reduced Wrinkles - SEC Filing

THOMSON REUTERS
·
Jul 16

Azitra - Announces Breakthrough Ex Vivo Results for Atr-cosf Program - SEC Filing

THOMSON REUTERS
·
Jul 16

Azitra - Ex Vivo Data Shows Increased Rhdfilaggrin Distribution in Human Skin - SEC Filing

THOMSON REUTERS
·
Jul 16

Azitra Posts Ex Vivo Anti-wrinkle, Repeat-dose Distribution Gains for Atr-cosf Program

Reuters
·
Jul 15

Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?

Benzinga
·
Jun 19

Azitra says shareholder letter is available

Reuters
·
Jun 17

Azitra - to Pause Further Enrollment in Atr-12 Trial to Redirect Funds to Atr-Cosf

THOMSON REUTERS
·
Jun 17

Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond

THOMSON REUTERS
·
Jun 17

Top Premarket Gainers

MT Newswires Live
·
Jun 17

Azitra COO Whitfill presents at BIO International Convention

Reuters
·
Jun 17

Azitra shareholders back increase in authorized common shares to 750 million at annual meeting

Reuters
·
Jun 16

BRIEF-Azitra Announces Intention To Adjourn Annual Meeting And Reconvene Annual Meeting

Reuters
·
May 28

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

THOMSON REUTERS
·
May 28

Azitra files to sell 255.7M shares of common stock for holders

TIPRANKS
·
May 22

Anitra Q1 EPS $(0.25) Misses $(0.12) Estimate

Benzinga
·
May 13

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

THOMSON REUTERS
·
May 13

Azitra Q1 FY26 net loss widens to $3.9 million; G&A expenses rise to $2.4 million

Reuters
·
May 13

Azitra wins new US patent protecting ATR-12 Netherton syndrome program

Reuters
·
May 06

Azitra, Inc. Announces New U.S. Patent Protecting Atr-12 Program

THOMSON REUTERS
·
May 06

Azitra presents preclinical ATR-01 data supporting first-in-human ichthyosis vulgaris trial planning

Reuters
·
Apr 28